Radiotherapy & Oncology
Volume 97, Issue 3 , Pages 521-524, December 2010

Feasibility of contrast-enhanced cone-beam CT for target localization and treatment monitoring

  • Jan Rødal

      Affiliations

    • Department of Medical Physics, The Norwegian Radium Hospital, Oslo University Hospital, Norway
    • Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway
    • Corresponding Author InformationCorresponding author. Address: Department of Medical Physics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway.
  • ,
  • Åste Søvik

      Affiliations

    • Department of Radiation Biology, The Norwegian Radium Hospital, Oslo University Hospital, Norway
    • Department of Companion Animal Clinical Sciences, Norwegian School of Veterinary Science, Oslo, Norway
  • ,
  • Hege Kippenes Skogmo

      Affiliations

    • Department of Companion Animal Clinical Sciences, Norwegian School of Veterinary Science, Oslo, Norway
  • ,
  • Ingerid Skjei Knudtsen

      Affiliations

    • Interventional Centre, Oslo University Hospital, Norway
  • ,
  • Eirik Malinen

      Affiliations

    • Department of Medical Physics, The Norwegian Radium Hospital, Oslo University Hospital, Norway

Received 19 March 2010; received in revised form 14 June 2010; accepted 3 July 2010. published online 28 July 2010.

Abstract 

A dog with a spontaneous maxillary tumour was given 40Gy of fractionated radiotherapy. At five out of 10 fractions cone-beam CT (CBCT) imaging before and after administration of an iodinated contrast agent were performed. Contrast enhancement maps were overlaid on the pre-contrast CBCT images. The tumour was clearly visualized in the images thus produced.

Keywords: Cone-beam CT, Contrast agent, Image guided radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(10)00389-0

doi:10.1016/j.radonc.2010.07.006

Radiotherapy & Oncology
Volume 97, Issue 3 , Pages 521-524, December 2010